Smith & Nephew Investor

Smith & Nephew is an industry leader in each of our three main Global Business Units - Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. These businesses jointly offer over 1,000 product ranges.
Smith & Nephew’s global infrastructure continues to expand each year. Smith & Nephew currently operates in 32 countries and generate annual sales of $3.4 billion. Substantial investment in their products and intensive research and development means that they are always ahead. Figures from last year show that they stand at number one as the leading company in Arthroscopy. Smith & Nephew is the second largest organisation in Advanced Wound Management and number three in Trauma and Clinical Therapies.
Industry: Preventive Medicine
Headquarters: London, England, United Kingdom
Founded Date: 1856
Employees Number: 10001+
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: 1

Visit Website
investor.enquiry@smith-nephew.com
@smithnephewplc
Register and Claim Ownership